
Releases
CurifyLabs Secures $14 Million to Scale 3D-Printed Drug Manufacturing
With $14 million in new Series A funding, Helsinki-based CurifyLabs is betting that 3D printing can modernize the slow, manual world of pharmacy compounding. The round, co-led by Sandwater and HealthCap, provides the capital necessary to accelerate U.S. expansion and ramp up the production of its automated medication systems.






















